399 related articles for article (PubMed ID: 2013383)
41. Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases.
Griga T; Tromm A; Müller KM; May B
Eur J Gastroenterol Hepatol; 2000 May; 12(5):559-64. PubMed ID: 10833101
[TBL] [Abstract][Full Text] [Related]
42. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.
Ellerbroek PM; Oudkerk Pool M; Ridwan BU; Dolman KM; von Blomberg BM; von dem Borne AE; Meuwissen SG; Goldschmeding R
J Clin Pathol; 1994 Mar; 47(3):257-62. PubMed ID: 8163698
[TBL] [Abstract][Full Text] [Related]
43. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M
World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442
[TBL] [Abstract][Full Text] [Related]
44. Association of primary sclerosing cholangitis with HLA-B8.
Chapman RW; Varghese Z; Gaul R; Patel G; Kokinon N; Sherlock S
Gut; 1983 Jan; 24(1):38-41. PubMed ID: 6600227
[TBL] [Abstract][Full Text] [Related]
45. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium.
Mandal A; Dasgupta A; Jeffers L; Squillante L; Hyder S; Reddy R; Schiff E; Das KM
Gastroenterology; 1994 Jan; 106(1):185-92. PubMed ID: 7506217
[TBL] [Abstract][Full Text] [Related]
46. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study.
Sandborn WJ; Landers CJ; Tremaine WJ; Targan SR
Mayo Clin Proc; 1996 May; 71(5):431-6. PubMed ID: 8628021
[TBL] [Abstract][Full Text] [Related]
47. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH
Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908
[TBL] [Abstract][Full Text] [Related]
48. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings.
Habior A; Rawa T; Orłowska J; Sankowska M; Lewartowska A; Tilszer A; Pawlak J; Krawczyk M; Butruk E
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):787-91. PubMed ID: 12169991
[TBL] [Abstract][Full Text] [Related]
49. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells.
Sakamaki S; Takayanagi N; Yoshizaki N; Hayashi S; Takayama T; Kato J; Kogawa K; Yamauchi N; Takemoto N; Nobuoka A; Ayabe T; Kohgo Y; Niitsu Y
Gut; 2000 Aug; 47(2):236-41. PubMed ID: 10896915
[TBL] [Abstract][Full Text] [Related]
50. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.
Orth T; Kellner R; Diekmann O; Faust J; Meyer zum Büschenfelde KH; Mayet WJ
Clin Exp Immunol; 1998 Jun; 112(3):507-15. PubMed ID: 9649223
[TBL] [Abstract][Full Text] [Related]
51. [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract].
Lamproye A; Belaiche J; Louis E; Salmon J; Mahieu P
Acta Gastroenterol Belg; 1994; 57(2):171-6. PubMed ID: 8053303
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis.
Roozendaal C; Horst G; Pogány K; van Milligen de Wit AW; Kleibeuker JH; Haagsma EB; Limburg PC; Kallenberg CG
Adv Exp Med Biol; 1998; 443():313-9. PubMed ID: 9781375
[TBL] [Abstract][Full Text] [Related]
53. Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis.
Nielsen MJ; Thorburn D; Leeming DJ; Hov JR; Nygård S; Moum B; Saffioti F; Gilja OH; Boberg KM; Mazza G; Røsjø H; Pinzani M; Karlsen TH; Karsdal MA; Vesterhus M
Aliment Pharmacol Ther; 2018 Jul; 48(2):179-189. PubMed ID: 29851098
[TBL] [Abstract][Full Text] [Related]
54. Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
Bosso MC; Marchesa PE; Ricchiuti A; Giacardi A; Cocchis D; Campi M; Palisi M; Salizzoni M
Transplant Proc; 2009 May; 41(4):1390-2. PubMed ID: 19460568
[TBL] [Abstract][Full Text] [Related]
55. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines.
Terjung B; Spengler U; Sauerbruch T; Worman HJ
Gastroenterology; 2000 Aug; 119(2):310-22. PubMed ID: 10930366
[TBL] [Abstract][Full Text] [Related]
56. Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.
Snook JA; Lowes JR; Wu KC; Priddle JD; Jewell DP
Gut; 1991 Feb; 32(2):163-6. PubMed ID: 1864535
[TBL] [Abstract][Full Text] [Related]
57. An autoantibody profile in primary sclerosing cholangitis.
Zauli D; Schrumpf E; Crespi C; Cassani F; Fausa O; Aadland E
J Hepatol; 1987 Aug; 5(1):14-8. PubMed ID: 3498749
[TBL] [Abstract][Full Text] [Related]
58. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.
Roozendaal C; Van Milligen de Wit AW; Haagsma EB; Horst G; Schwarze C; Peter HH; Kleibeuker JH; Tervaert JW; Limburg PC; Kallenberg CG
Am J Med; 1998 Nov; 105(5):393-9. PubMed ID: 9831423
[TBL] [Abstract][Full Text] [Related]
59. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease.
Proujansky R; Fawcett PT; Gibney KM; Treem WR; Hyams JS
J Pediatr Gastroenterol Nutr; 1993 Aug; 17(2):193-7. PubMed ID: 8229547
[TBL] [Abstract][Full Text] [Related]
60. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
Folwaczny C; Fricke H
Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
